Short chain fatty acids enhance expression and activity of the umami taste receptor in enteroendocrine cells via a Gi/o pathway
However, patients taking them alongside other diabetes medications (particularly insulin or sulphonylureas) have an increased risk of hypoglycaemic episodes, which commonly present with fatigue, weakness, and confusion
Initially focused on managing type 2 diabetes, it would not be until 2014 that Novo Nordisks introduction of another GLP-1 agonist, Saxenda, marked a pivotal shift towards weight loss
How long have you been at your current weight
This content is for informational and educational purposes only and does not replace medical advice, diagnosis, or treatment
Understanding when to stop is a critical part of managing Ozempic and diverticulitis safely